9 year-old female with papillary thyroid...

24
9 year-old Female with Papillary Thyroid Cancer Katie O’Sullivan, M.D. Fellow Medicine/Pediatric Endocrinology Thursday, January 16 th , 2014

Upload: others

Post on 25-Jul-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

9 year-old Female with Papillary Thyroid CancerKatie O’Sullivan, M.D.FellowMedicine/Pediatric EndocrinologyThursday, January 16th, 2014

Chief Complaint

Mass on the right side of the neck x 2-3 weeks at 8yr 0 mo

History of Present Illness

Right neck mass identified x 2-3 wksTender x 1 dayTreated with course of steroids and antibiotics

General: Denies fever, fatigue, anorexia, weight loss, night sweats

HEENT: Denies congestion, rhinorrhea, sore throat, dysphagia, hoarseness

No history of radiation exposure

More HistoryMore History……

Birth History:

Neonatal jaundice

Past Medical/Surgical History:

Recurrent otitis media

Allergies:

Cephalosporins

Immunizations: Up-To-Date

Developmental History:

No delayed milestones

Medications:

Clindamycin

Social History:

2nd grade

Lives in Indiana with family, 2 dogs. No exposure to cats.

Family History:

No family history of thyroid cancer.

Review of Systems

Eyes: Negative for visual disturbance.

Respiratory: Negative for cough or shortness of breath.

Cardiovascular: Negative for palpitations or chest pain.

Gastrointestinal: Negative for abdominal pain, nausea, vomiting, diarrhea, constipation.

Genitourinary: Negative for urgency, frequency and enuresis.

Musculoskeletal: Negative for arthralgias, edema.

Skin: Negative for acne, rash, dry skin.

Neurological: Negative for headaches. +intermittent tremulousness.

Psychiatric/Behavioral: Negative for behavioral problems.

Physical Exam

Vital Signs: BP 92/33, P 67, R 17, Wt 36.7kg (85%), Ht 131 cm (70 %), BMI 21.4 (96%)

General: Well-developed, no distress.

HEET: Conjunctiva clear, EOMI, PERRL, nasal turbinates normal, tongue normal, 2+ tonsils.

Neck: supple, trachea midline, small jugulodigastric LN on left and 3 discrete firm, non-mobile LN on the right neck. No palpable thyroid or thyroid nodules.

Axilla: No lymphadenopathy.

CV: RRR, no murmur, no extremity edema.

Pulmonary: CTAB, no crackles or wheezing.

Abdomen: soft, non-tender, non-distended.

Neuro: alert, 2+ patellar reflexes.

Skin: warm, no diaphoresis.

Laboratory/Imaging Studies

Ca 10

137

4

99

27 0.43

1577

CBC: WBC 11.8, Hgb 13, Plt 375

72%PMN, 18.3%Lymph, 6.9%Mono, 2.2%Eos

CT Neck (outside film):• Multiple matted LN extending under the SCM, some

of which had a necrotic center• Bilateral thyroid masses

Next Step: Neck LN biopsy under general anesthesia

Findings: 3-4 hard LN anterior and beneath the right SCM

Procedure: Excision of 2 right-sided LN measuring 1cm and 2cm.

Pathology:Papillary thyroid carcinomaExtra-nodal extension present

Total Thyroidectomy 8/15/2012

Procedure: Total thyroidectomy, right modified radical neck dissection, paratracheal and pretracheal node dissection

Pathology: Papillary thyroid cancer, chronic lymphocytic thyroiditis

Thyroid gland: 2.5cm nodule and widely-invasive cancer in bilateral lobes and isthmus; capsular invasion, positive margins

Lymph Nodes: 32/51 nodes positive

Extranodal extension present

Post-Op

TSH 13.3

FT4 0.85

Ca 7.8

Phos 4.4

PTH 4

Vit D 25-OH 26

Started:LT4 3mcg/kg

(112mcg/d)Calcium carbonate

1250mg po q6hCholecalciferol

2000IU dailyCalcitriol 0.5mcg qd

Next step in management?

Post-Operative Management

Labs 12/2012: Anti-Tg AB 630 IU/mL (nl <22)

Pre-RAI scan: 2.15mCi I-131

RAI ablation 1/2013: 60mCi I-131

Post-therapy RAI scan

6-month post-RAI scan 7/2013: 1.5mCi I- 131

TSH and Free T4 Trend

01234567

Oct

-12

Nov

-12

Dec

-12

Jan-

13

Feb-

13

Mar

-13

Apr

-13

May

-13

Jun-

13

Jul-1

3

Aug

-13

Sep

-13

Oct

-13

Nov

-13

Dec

-13

Date

TSHFree T4

Clinical Questions

How do you determine the prognosis of children with differentiated thyroid cancer?

What is the standard goal thyrotropin for children s/p thyroidectomy for differentiated thyroid cancer?

Well-Differentiated Thyroid Cancer (WDTC) in Children

Accounts for 3-13% of all WDTC

Most common endocrine malignancy in children

Children present with more extensive disease than adults

Mortality is low

Dinauer et al. Curr Opin Onc. 2008.Rachmiel et al. Ped Endo Metab 2008.Shayota et al. Surgery 2013.Zimmerman et al. Surgery 1988.

Calculating Prognosis of Well- Differentiated Thyroid Cancer

Cooper et al. Thyroid 2009.

Shayota et al. Surgery 2013.

Shayota et al. Surgery 2013.

Clinical Questions

How do you determine the prognosis of children with differentiated thyroid cancer?

What is the standard goal thyrotropin for children s/p thyroidectomy for differentiated thyroid cancer?

TSH Suppression Therapy

Adults:

Pediatrics: ???

Cooper et al. Thyroid 2009.

Royal Marsden Hospital – 2000.

Landau et al. European Journal of Cancer 2000.

Royal Marsden Hospital – 2000.

Landau et al. European Journal of Cancer 2000.

Conclusion

WDTC is the most common endocrine cancer in children

Poor prognostic factors for children with WDTC include male gender, larger primary tumor size and presence of distant metastasis

Surgical and RAI therapy in children with WDTC is still controversial

TSH suppression therapy may be beneficial, however the goal TSH has not been well- described in children

Works Cited

Cooper et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19(11):1-47.

Dinauer et al. Differentiated thyroid cancer in children: diagnosis and management. Current Opinion in Oncology 2008;20:59-65.

Landau et al. Thyroid cancer in children: the Royal Marsden Hospital experience. European Journal of Cancer 2000. 36:214-220.

Rachmiel et al. Evidence-based review of treatment and follow-up of pediatric patients with differentiated thyroid carcinoma. Journal of Pediatric Endocrinology and Metabolism 2006; 19:1377-1393.

Rapkin L and Pashankar FD. “Management of thyroid carcinoma in children and young adults.” Journal of Pediatric Hematology and Oncology 2012; 34(supp 2):S39-S46.

Shayota et al. MeSS: A novel prognostic scale specific for pediatric well- differentiated thyroid cancer: A population-based, SEER outcomes study. Surgery 2013; 154:429-35.

Zimmerman et al. Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades. Surgery 1988;104:1157-1166.